GlassScriptPhysician profile
Andrew Moss Becker
NPI 1053379487
$2,141.07
in general payments reported to CMS, 2019-2025
15 companies · $1,005 in 2025
The $1,005 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.55 · 2020: $25.44 · 2021: $125 · 2022: $367 · 2023: $208 · 2024: $365 · 2025: $1,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788 · Consulting Fee: $760 · Education: $30.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.19 |
| Consulting Fee | $760.00 |
| Education | $30.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $859.50 | 2022-2025 | Fintepla |
| Abbvie INC. | $409.34 | 2021-2025 | Ubrelvy, Qulipta |
| Neurelis, INC. | $169.90 | 2021-2024 | Valtoco |
| Sk Life Science, INC. | $168.02 | 2021-2024 | Xcopri |
| Livanova USA, INC. | $137.60 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Lilly USA, LLC | $114.14 | 2025 | Kisunla |
| Avanir Pharmaceuticals, INC. | $81.68 | 2022 | |
| Acadia Pharmaceuticals INC | $35.26 | 2025 | Nuplazid |
| Sunovion Pharmaceuticals INC. | $31.86 | 2019 | |
| Alexion Pharmaceuticals, INC. | $30.84 | 2021 | |
| Supernus Pharmaceuticals, INC. | $25.44 | 2020 | |
| Argenx US, INC. | $25.28 | 2022 | |
| Daiichi Sankyo INC. | $21.80 | 2024 | Injectafer |
| Catalyst Pharmaceuticals, INC. | $16.72 | 2024 | |
| Upsher-Smith Laboratories LLC | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.